• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型1,10-菲咯啉和5-氨基-1,10-菲咯啉衍生物的抗肿瘤活性

Antitumour activity of novel 1,10-phenanthroline and 5-amino-1,10-phenanthroline derivatives.

作者信息

Wesselinova Diana, Neykov Mihail, Kaloyanov Nikolay, Toshkova Reneta, Dimitrov Georgi

机构信息

Institute of Experimental Pathology and Parasitology, Bulgarian Academy of Sciences, Acad. G. Bonchev Street, Bl. 25, 1113 Sofia, Bulgaria.

出版信息

Eur J Med Chem. 2009 Jun;44(6):2720-3. doi: 10.1016/j.ejmech.2009.01.036. Epub 2009 Feb 10.

DOI:10.1016/j.ejmech.2009.01.036
PMID:19249137
Abstract

Synthesis and impact on the tumour growth of palladium(II) complex of 5-amino-1,10-phenanthroline Pd(5-NH(2)-phen)(2)(NO(3))(2) and the protonated dimer (phen)(2)(H(+))(BF(4)(-)) have been described. In the reported experiments a cancerous (100% lethality) myeloid subcutaneous tumour (with Graffi-tumour origin) in hamsters was used. The animals were injected i.p. with different doses of the substances. The longest mean survival time (1.65 times longer than the controls) was achieved when the substance Pd(5-NH(2)-phen)(2)(NO(3))(2) was injected into the animals. One of the animals even survived until the 71st day, which is 2.2 times longer than the controls. The compound (phen)(2)(H(+))(BF(4)(-)) prolonged the mean life-time of the animals 1.4 times in comparison to the controls. On the other hand, the Pd(II) complex of 1,10-phenanthroline, Pd(phen)(2)(H(2)O)(NO(3))(2), did not reveal any antitumour activity. Our experience concerning the effect of other drugs on this tumour has shown a survival time no longer than 4-5d after the death of the controls.

摘要

已描述了5-氨基-1,10-菲咯啉钯(II)配合物Pd(5-NH(2)-phen)(2)(NO(3))(2)以及质子化二聚体(phen)(2)(H(+))(BF(4)(-))的合成及其对肿瘤生长的影响。在报道的实验中,使用了仓鼠的一种癌性(100%致死率)髓样皮下肿瘤(起源于格拉夫氏肿瘤)。给动物腹腔注射不同剂量的这些物质。当向动物注射物质Pd(5-NH(2)-phen)(2)(NO(3))(2)时,实现了最长的平均存活时间(比对照组长1.65倍)。其中一只动物甚至存活到了第71天,这比对照组长2.2倍。化合物(phen)(2)(H(+))(BF(4)(-))使动物的平均寿命比对照组延长了1.4倍。另一方面,1,10-菲咯啉的钯(II)配合物Pd(phen)(2)(H(2)O)(NO(3))(2)未显示出任何抗肿瘤活性。我们关于其他药物对这种肿瘤影响的经验表明,在对照组死亡后存活时间不超过4 - 5天。

相似文献

1
Antitumour activity of novel 1,10-phenanthroline and 5-amino-1,10-phenanthroline derivatives.新型1,10-菲咯啉和5-氨基-1,10-菲咯啉衍生物的抗肿瘤活性
Eur J Med Chem. 2009 Jun;44(6):2720-3. doi: 10.1016/j.ejmech.2009.01.036. Epub 2009 Feb 10.
2
Self-assembly of novel molecular complexes of 1,10-phenanthroline and 5-amino-1,10-phenanthroline and evaluation of their in vitro antitumour activity.新型 1,10-菲啰啉和 5-氨基-1,10-菲啰啉分子配合物的自组装及其体外抗肿瘤活性评价。
Eur J Med Chem. 2011 Jun;46(6):1992-6. doi: 10.1016/j.ejmech.2011.02.018. Epub 2011 Mar 3.
3
Cytotoxicity and effects of 1,10-phenanthroline and 5-amino-1,10-phenanthroline derivatives on some immunocompetent cells.细胞毒性及 1,10-菲咯啉和 5-氨基-1,10-菲咯啉衍生物对一些免疫活性细胞的影响。
Eur J Med Chem. 2009 Dec;44(12):5099-102. doi: 10.1016/j.ejmech.2009.07.016. Epub 2009 Jul 22.
4
Chiral cyclopalladated complexes derived from N,N-dimethyl-1-phenethylamine with bridging bis(diphenylphosphine)ferrocene ligand as inhibitors of the cathepsin B activity and as antitumoral agents.以N,N-二甲基-1-苯乙胺为原料、桥连双(二苯基膦)二茂铁配体为配体衍生得到的手性环钯配合物,作为组织蛋白酶B活性抑制剂和抗肿瘤剂。
Bioorg Med Chem. 2005 Apr 15;13(8):3047-55. doi: 10.1016/j.bmc.2005.01.057.
5
Hairpin-shaped tetranuclear palladium(II) complex: synthesis, crystal structure, DNA binding and cytotoxicity activity studies.发夹状四核钯(II)配合物的合成、晶体结构、DNA 结合及细胞毒性活性研究。
Eur J Med Chem. 2010 Jul;45(7):2784-90. doi: 10.1016/j.ejmech.2010.02.061. Epub 2010 Mar 7.
6
Direct synthesis of a new class of N,N,N ligands based on 1,2-dihydro-1,10-phenanthroline backbone and their coordination to Pd complexes.基于1,2-二氢-1,10-菲咯啉骨架的新型N,N,N配体的直接合成及其与钯配合物的配位作用。
Dalton Trans. 2009 Feb 7(5):770-2. doi: 10.1039/b817726k. Epub 2008 Dec 12.
7
Pyrophosphate-bridged complexes with picomolar toxicity.具有皮摩尔毒性的焦磷酸桥连配合物。
J Inorg Biochem. 2009 Sep;103(9):1254-64. doi: 10.1016/j.jinorgbio.2009.07.010. Epub 2009 Jul 17.
8
Synthesis, characterization and cytotoxicity of lanthanum(III) complexes with novel 1,10-phenanthroline-2,9-bis-alpha-amino acid conjugates.镧(III)与新型1,10-菲咯啉-2,9-双-α-氨基酸共轭物的配合物的合成、表征及细胞毒性
Anticancer Drug Des. 2000 Dec;15(6):405-11.
9
Preliminary fluorimetric screening of fourteen palladium complexes as potential antitumor agents.对十四种钯配合物作为潜在抗肿瘤药物进行初步荧光筛选。
Sci China B. 1993 Oct;36(10):1216-23.
10
Synthesis, structural characterization, and antitumor activity of palladium(II) complexes containing a sugar unit.含糖单元的钯(II)配合物的合成、结构表征及抗肿瘤活性
Bioorg Med Chem Lett. 2004 May 17;14(10):2533-6. doi: 10.1016/j.bmcl.2004.02.095.

引用本文的文献

1
Revisiting Fused-Pyrrolo-1,10-Phenanthroline Derivatives: Novel Transformations and Stability Studies.重新审视稠合吡咯并[1,10]菲咯啉衍生物:新型转化及稳定性研究
ChemistryOpen. 2025 Jul;14(7):e202400365. doi: 10.1002/open.202400365. Epub 2025 May 6.
2
Anticancer Potential of Azatetracyclic Derivatives: In Vitro Screening and Selective Cytotoxicity of Azide and Monobrominated Compounds.氮杂四环衍生物的抗癌潜力:叠氮化物和单溴化物的体外筛选及选择性细胞毒性
Molecules. 2025 Feb 5;30(3):702. doi: 10.3390/molecules30030702.
3
Self-Assembled Molecular Complexes of 1,10-Phenanthroline and 2-Aminobenzimidazoles: Synthesis, Structure Investigations, and Cytotoxic Properties.
1,10-菲咯啉与 2-氨基苯并咪唑自组装分子配合物的合成、结构研究及细胞毒性性质。
Molecules. 2024 Jan 24;29(3):583. doi: 10.3390/molecules29030583.
4
Zinc Complexes with Nitrogen Donor Ligands as Anticancer Agents.含氮供体配体的锌配合物作为抗癌剂。
Molecules. 2020 Dec 9;25(24):5814. doi: 10.3390/molecules25245814.
5
Design, Synthesis, Molecular Modelling and Anticancer Activities of New Fused Phenanthrolines.新型稠合菲咯啉的设计、合成、分子模拟及抗癌活性研究。
Molecules. 2020 Jan 25;25(3):527. doi: 10.3390/molecules25030527.
6
2,9-Bis(trichloro-meth-yl)-1,10-phenanthroline.2,9-双(三氯甲基)-1,10-菲咯啉
Acta Crystallogr Sect E Struct Rep Online. 2010 Jan 23;66(Pt 2):o424. doi: 10.1107/S1600536810002035.